ZILRANQUI
Live / Applied — Fifth extension granted (statement of use) (as of 13 Mar 2026)
What this means for you
Not registered yet, but its 12 Apr 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97359200
- Mark type
- Stylized text
- Filed
- 12 Apr 2022
- Published for opposition
- 14 Mar 2023
- Attorney of record
- Lisa M. Dellamura
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in Oncology
Owner
- MERCK SHARP & DOHME LLC, RAHWAY, NJ, US
- MERCK SHARP & DOHME LLC, RAHWAY, NJ, US
- Merck Sharp & Dohme Corp., Whitehouse Station, NJ, US
Prosecution history
- 13 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Mar 2026 — SOU EXTENSION 5 GRANTED
- 10 Oct 2025 — SOU EXTENSION 5 FILED
- 12 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Apr 2025 — SOU EXTENSION 4 GRANTED
- 23 Apr 2025 — SOU EXTENSION 4 FILED
- 23 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Oct 2024 — SOU EXTENSION 3 GRANTED
- 21 Oct 2024 — SOU EXTENSION 3 FILED
- 21 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 23 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Apr 2024 — SOU EXTENSION 2 GRANTED